Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > What was expected in the last CC fell flat.
View:
Post by StockscoutX on Apr 26, 2021 6:17pm

What was expected in the last CC fell flat.

What was expected from StageZero and what shareholders got was total opposite. Had StageZero been connected to a major partner with wide distribution to any clinic and hospitals world wide then it's anybodies guess how high the SP would of went because of how much revenues it could have possibly generated.

Instead, StageZero did a 180 degree shift and went small time. Therefore, who knows when and how much market it would get for Aristotle in the long run. Moreover, there is no way to estimate how much revenues they will generate going forward.

Also, the competition will likely catch up to them and would deal another blow to expand market share.

I believe it's all for those reasons why SP fell as it did. Odds are the next QR and news to come are already baked in the SP.

Call it a bash but I call it reality from my point of vue and analysis.
Comment by Mykndrsn on Apr 26, 2021 6:30pm
So sell. Looking for reassurance? Have the courage and quit blathering, your opinion isn't valuable to anyone but yourself and you still seem to need convincing. See ya! 
Comment by Liked2Think on Apr 26, 2021 7:16pm
Them doing this current plan isnt what is bad.  In the end its the right way to go.  Would had been nice if they had decided to say this had to be this way at any point leading up to it but thats not Stage's way. The problem is the timing now.   LOI signed off end of June lets say. Time table to get the new company together and integrate them into Stage's systems When ...more  
Comment by davewho on Apr 26, 2021 7:59pm
500k in cancer testing was for all 2020 not Q4. Its still quite impressive though. At $300 per test thats over 1600 cancer tests. If they can convert those to Artistotle the rev would be 5x the amount.  If someone with a silver tongue wants to call or email the Care Oncology Case Manager and say they saw the Artistotle write up in Canadian Biotech Launches Screening Panel for Detecting ...more  
Comment by Jonnyboy85 on Apr 26, 2021 8:05pm
I think it was about $370000 in just q4, if you look at the quarterlies, so it ramped up very dramatically right at the end of the year.
Comment by davewho on Apr 26, 2021 8:13pm
still quite an impressive rev number. We will be watching Q1 with interest to see if the ramp up in cancer testing continues.
Comment by IainCaimbeul on Apr 26, 2021 8:15pm
YOU did not know the $473K was for the entire year (as I pointed out in an earlier post, it was for 2020) pay attention to the detail. Why don't you do the call?
Comment by IainCaimbeul on Apr 26, 2021 8:08pm
Good post . God forbid that you might dis-agree with the cheerleaders on the board. Guess that makes you a basher :) Honest discusion is discouraged, might disrupt the agenda/narrative. I sense panic!  I am staying for the long run. I can afford it! Slainte Mhath  -Scottish Gailec for Good Health/Cheers
Comment by Mykndrsn on Apr 26, 2021 8:49pm
Low information turds turning up daily to disparage the company is your idea of honest discussion. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities